Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

We Should Let the Banks Burn Down

Bob Moriarty of 321 Gold explains why he believes banks should be allowed to fail. In later 2008 during what is now referred to as the Great Financial Crisis, government and financial managers had an opportunity to reset a badly out of balance banking system....
Streetwise Reports | August 7, 2019 |

Coronavirus And The Coming Financial Revolution

The coronavirus pandemic is one of the biggest and unprecedented seismic shifts in the global economy that we've ever seen in modern history, and it's just getting started. Already, economies around the world are shutting down. The federal reserve has pumped trillions int...
Michael Kern | April 15, 2020 |

Myovant Sciences Shares Rise on NDA Filing for Uterine Fibroid Combination Therapy Drug

Shares of Myovant Sciences traded 40% higher after the company reported that it has submitted a New Drug Application to the FDA for once-daily relugolix combination tablet for the treatment of women with uterine fibroids. Healthcare company Myovant Sciences Ltd. (...
Streetwise Reports | June 2, 2020 |

Revolutionizing Energy

Click here to Access the Report.
Jocelyn Aspa | March 20, 2023 |

MXR seeking sedimentary copper in Colombia

West of Glen Canyon, Utah, a 90-million-year-old secret is hidden beneath the dry, desolate landscape. What is now one of the largest sand-dune deserts in the world, was once the middle of a vast inland ocean. Plying the waters of the Western Inland Seaway , a human transpo...
Richard (Rick) Mills | November 5, 2019 |

Hemostemix Founder: A Man with a Compassionate Heart

The Canadian stem cell company Hemostemix Inc. ( TSX-V: HEM , OTC: HMTXF ) was founded by a man who truly had a compassionate heart and a clear intent to establish a breakthrough in heart disease using the same technology that saved his life. Roger Bergersen, who train...
Featured Submission | December 14, 2020 |

3D printing is a manufacturing game-changer

Calling all carnivores: ever thought about getting a meat printer? Of hand-crafting delectable beef steaks at home from plant proteins, that have the same texture, appearance and flavor as real meat, only without the distasteful killing part? 3D-printed steaks and chicken ...
Richard (Rick) Mills | November 15, 2019 |

Calima Energy (ASX:CE1) reports record production for Q3 2022

Calima Energy (ASX:CE1) has achieved record production of 382,910 boe in Q3 2022.
Trevor Abes | November 3, 2022 |

Rising Star Trillion Energy Ready to Supply Much Needed European Gas

Trillion Energy (CSE:TCF) is a company poised to bring on desperately needed natural gas production within weeks to the European market.
John Ballem | September 26, 2022 |

Stemline Shares Take Off on $677 Million Buyout Offer by Global Pharmaceutical Firm

Shares of Stemline Therapeutics traded 150% higher after the company reported that it has entered into a definitive agreement to be acquired by Italy's Menarini Group in a deal valued at up to $677 million. Stemline Therapeutics Inc. (STML:NASDAQ) , which is...
Streetwise Reports | May 5, 2020 |
1 2 3 4 5 6 7 8 9 10 ...